Cochrane Abstracts
Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pembrolizumab Monotherapy Versus Chemotherapy for Treatment of Advanced Urothelial Carcinoma With Disease Progression During or Following Platinum‐containing Chemotherapy. a Cochrane Rapid Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439432/all/Pembrolizumab_monotherapy_versus_chemotherapy_for_treatment_of_advanced_urothelial_carcinoma_with_disease_progression_during_or_following_platinum‐containing_chemotherapy__A_Cochrane_Rapid_Review_New. Accessed 07 June 2023.
Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439432/all/Pembrolizumab_monotherapy_versus_chemotherapy_for_treatment_of_advanced_urothelial_carcinoma_with_disease_progression_during_or_following_platinum‐containing_chemotherapy__A_Cochrane_Rapid_Review_New. Accessed June 7, 2023.
Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439432/all/Pembrolizumab_monotherapy_versus_chemotherapy_for_treatment_of_advanced_urothelial_carcinoma_with_disease_progression_during_or_following_platinum‐containing_chemotherapy__A_Cochrane_Rapid_Review_New
Pembrolizumab Monotherapy Versus Chemotherapy for Treatment of Advanced Urothelial Carcinoma With Disease Progression During or Following Platinum‐containing Chemotherapy. a Cochrane Rapid Review [Internet]. In: Cochrane Abstracts. [cited 2023 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439432/all/Pembrolizumab_monotherapy_versus_chemotherapy_for_treatment_of_advanced_urothelial_carcinoma_with_disease_progression_during_or_following_platinum‐containing_chemotherapy__A_Cochrane_Rapid_Review_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review
ID - 439432
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439432/all/Pembrolizumab_monotherapy_versus_chemotherapy_for_treatment_of_advanced_urothelial_carcinoma_with_disease_progression_during_or_following_platinum‐containing_chemotherapy__A_Cochrane_Rapid_Review_New
DB - Evidence Central
DP - Unbound Medicine
ER -
